Co-Authors
This is a "connection" page, showing publications co-authored by Nathalie Chavarot and Anne Scemla.
Connection Strength
2.626
-
Weak antibody response to three doses of mRNA vaccine in kidney transplant recipients treated with belatacept. Am J Transplant. 2021 12; 21(12):4043-4051.
Score: 0.967
-
Poor Anti-SARS-CoV-2 Humoral and T-cell Responses After 2 Injections of mRNA Vaccine in Kidney Transplant Recipients Treated With Belatacept. Transplantation. 2021 09 01; 105(9):e94-e95.
Score: 0.965
-
Decline and loss of anti-SARS-CoV-2 antibodies in kidney transplant recipients in the 6 months following SARS-CoV-2 infection. Kidney Int. 2021 02; 99(2):486-488.
Score: 0.232
-
Ig-responsive relapsing inflammatory syndrome following COVID-19 in a kidney transplant recipient. Kidney Int. 2021 03; 99(3):767-768.
Score: 0.231
-
COVID-19 severity in kidney transplant recipients is similar to nontransplant patients with similar comorbidities. Am J Transplant. 2021 03; 21(3):1285-1294.
Score: 0.231